Pharming Group (PHAR)
(Delayed Data from NSDQ)
$9.59 USD
-0.05 (-0.47%)
Updated May 15, 2024 01:52 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 0.01 |
EPS Last Quarter | -0.19 |
Last EPS Surprise | -2,000.00% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.03 |
Next Year | -0.01 |
EPS (TTM) | -0.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 74.45M | 75.55M | 289.31M | 336.54M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 76.90M | 79.10M | 296.40M | 348.60M |
Low Estimate | 72.00M | 72.00M | 285.40M | 321.10M |
Year ago Sales | 54.90M | 66.66M | 245.30M | 289.31M |
Year over Year Growth Est. | 35.61% | 13.34% | 17.94% | 16.32% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.01 | 0.36 | -0.03 | -0.01 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | NA | 0.01 | 0.02 | 0.07 |
High Estimate | 0.02 | 0.70 | 0.02 | 0.07 |
Low Estimate | 0.00 | 0.01 | -0.10 | -0.10 |
Year ago EPS | 0.02 | 0.05 | -0.14 | -0.03 |
Year over Year Growth Est. | -50.00% | 620.00% | 78.57% | 55.56% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 0 | 1 |
Up Last 30 Days | 0 | 1 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.01 | 0.36 | -0.03 | -0.01 |
7 Days Ago | 0.01 | 0.35 | -0.02 | -0.01 |
30 Days Ago | 0.01 | 0.35 | -0.02 | -0.01 |
60 Days Ago | 0.01 | 0.35 | -0.02 | -0.01 |
90 Days Ago | NA | NA | -0.06 | 0.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.01 | 0.01 | 0.02 | 0.07 |
Zacks Consensus Estimate | 0.01 | 0.36 | -0.03 | -0.01 |
Earnings ESP | 0.00% | -97.18% | 175.00% | 800.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.19 | -0.03 | 0.05 | 0.02 | NA |
Estimate | 0.01 | 0.05 | 0.13 | -0.02 | NA |
Difference | -0.20 | -0.08 | -0.08 | 0.04 | -0.08 |
Surprise | -2,000.00% | -160.00% | -61.54% | 200.00% | -505.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more